Answers are grounded in this paper and cite their sources.
There are many causes of lower extremity overgrowth. We present a 69-year-old female who was referred to the Boston Lymphatic Center due to left lower extremity enlargement. Her history and physical examination were inconsistent with lymphedema and a lymphoscintigram excluded this condition. She was hypothesized to have a condition on the PIK3CA -related overgrowth spectrum. The overgrown tissue was resected and to obtain a diagnosis, it was subjected to targeted next-generation sequencing, which showed an MTOR (NM_001386500:c.6644C>T (p.Ser2215Phe)) variant. This mutation has not been previously associated with lower extremity overgrowth.
No takes yet. Share an insight, caveat, or question.
Ad et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: